Be'eri Niego

Effective treatment of mouse metastatic prostate cancer by low electric field enhanced chemotherapy.

Oncostatin M is a neuroprotective cytokine that inhibits excitotoxic injury in vitro and in vivo.

Two conserved regions within the tissue-type plasminogen activator gene promoter mediate regulation by brain-derived neurotrophic factor.

Desmoteplase-mediated plasminogen activation and clot lysis are inhibited by the lysine analogue tranexamic acid.

Tissue-type plasminogen activator requires a co-receptor to enhance NMDA receptor function.

A nonfibrin macromolecular cofactor for tPA-mediated plasmin generation following cellular injury.

Thrombin-induced activation of astrocytes in mixed rat hippocampal cultures is inhibited by soluble thrombomodulin.

t-PA-specific modulation of a human blood-brain barrier model involves plasmin-mediated activation of the Rho kinase pathway in astrocytes.